Amanda Collier

Amanda graduated with a First in Molecular Cell Biology from the University of York in 2014. During her degree, she undertook a research placement at the Regenerative Medicine Unit at Pfizer Neusentis, where she studied the role of Sox2 in neural stem cells and reprogramming. Funded by an MRC Studentship (www.mrc.ac.uk/Fundingopportunities/Studentships), Amanda joined the Babraham Institute in 2014 to investigate the function and regulation of Polycomb-Group proteins in stem cell fate decisions.